Project Grant F31DA063126

Award Date 10/18/25
Completion Date 8/31/27
Dollars Obligated $98K
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Rhode Island, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $200,446 to the University of California, San Diego (UCSD) to conduct a mixed-methods study on the impact of novel housing programs on overdose outcomes among unhoused people who use drugs in San Diego, California. The key objectives of the study are to: 1) analyze longitudinal data on the effects of involuntary displacement and housing program...
This $45,452,044 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Opioid STR (CFDA 93.788) program will fund comprehensive initiatives to address opioid and stimulant misuse in Rhode Island over 3 years. The grant will serve 4,177 individuals through prevention, harm reduction, treatment, and recovery support services, with the potential to reach several thousand more through universal strategies. Key objectives include expanding primary...
The Department of Health and Human Services' Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $1,656,459 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) to the City of Providence, Rhode Island. The Providence Overdose Prevention Project will support first responders, with a focus on Emergency Medical Services, in citywide overdose prevention efforts among adults 18 years of age and...
This federal Project Grant award of $435,313 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to develop a cost-based epidemiological planning tool to guide public health response to the combined HIV, hepatitis C (HCV), and opioid use disorder (OUD) epidemics. Specifically, the project will: 1) Create an interactive, web-based dashboard to assist policymakers in planning an effective response and provide improved estimates...
This federal Project Grant award, with ID R01DA059503, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $1,192,612 grant will fund a 5-year research project by The Miriam Hospital, a non-profit healthcare and research institution in Providence, RI, to integrate HIV prevention services into clinical care settings for people with opioid use disorder (OUD). The key objectives of this multidisciplinary research...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) is aimed at implementing a low-threshold Hepatitis C (HCV) treatment strategy in a jail setting. The $252,042 award, effective September 15, 2024, will support a pilot study at Rhode Island Hospital to evaluate the feasibility and effectiveness of the "MINMON-J" approach, which modifies a minimal monitoring HCV treatment protocol for use...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $431,750 to Rutgers, The State University of New Jersey to conduct research on informing national overdose prevention and treatment strategies for high-risk adolescents. The key objectives of this 2-year project are to: 1) estimate the prevalence of adolescent nonfatal drug overdose and identify high-risk demographic and clinical subgroups,...
This Project Grant award of $2,316,128.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to design tailored harm reduction strategies to address the opioid overdose crisis across six distinct jurisdictions. The project, titled "REVERSING OVERDOSE EPIDEMICS THROUGH SIMULATION, COLLABORATION, AND UNIFIED EFFORTS (RESCUE)", will collaborate with health departments and community partners to assess the...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $722,876 to New York University School of Medicine to conduct a study characterizing complex opioid use disorder (OUD) care trajectories and outcomes following acute service utilization. The study aims to: 1) characterize real-world trajectories of OUD treatment in the year following hospital encounters among treatment-naive individuals and...
The National Institute on Drug Abuse (NIDA) awarded a Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) totaling $3,086,472 to the University of Rhode Island on September 15, 2024. The objective of this 5-year project is to evaluate the spillover effects of HIV interventions among marginalized populations, particularly young Black men who have sex with men (BMSM), who use illicit substances. The project will leverage data from three existing network studies in Chicago,...

A STATEWIDE EXAMINATION OF THE ADDRESS-LEVEL RELATIONSHIPS BETWEEN RESIDENTIAL EVICTION PROCEEDINGS AND OVERDOSE EVENTS IN RHODE ISLAND - PROPOSAL SUMMARY IN THE WAKE OF THE COVID-19 PANDEMIC, OVERDOSE MORTALITY AND AFFORDABLE HOUSING SHORTAGES HAVE REACHED UNPRECEDENTED LEVELS IN RHODE ISLAND AND ACROSS THE UNITED STATES. HOUSING INSECURITY IS A KNOWN RISK FACTOR FOR OVERDOSE, YET THE EFFECTS OF RESIDENTIAL EVICTION-A STRUCTURAL AND POLICY-SENSITIVE CAUSE OF HOUSING INSECURITY-ON OVERDOSE RISKS ARE UNDERSTUDIED. EVICTION IS A COMPLEX LEGAL PROCESS COMPOSED OF A SERIES OF STAGES, EACH OF WHICH MAY IMPACT OVERDOSE RISK AND THUS OFFERS OPPORTUNITY FOR PUBLIC HEALTH INTERVENTION. THE OBJECTIVE OF THIS PROPOSAL IS TO PURSUE A THOROUGH EXAMINATION OF THE RELATIONSHIP BETWEEN RESIDENTIAL EVICTION PROCEEDINGS (I.E., FILING, HEARING, AND ENFORCEMENT) AND OVERDOSE AT THE ADDRESS LEVEL IN RHODE ISLAND, TO BETTER INFORM EVICTION PREVENTION POLICIES THAT COMPLEMENT ONGOING HARM REDUCTION AND OVERDOSE PREVENTION EFFORTS. THE PROPOSED RESEARCH WILL LEVERAGE THE WEALTH OF CENTRALIZED, HIGH-RESOLUTION DATA AVAILABLE IN RHODE ISLAND-AND OUR TEAM'S ESTABLISHED RELATIONSHIP WITH THE STATE HEALTH DEPARTMENT-TO CONSTRUCT A LONGITUDINAL DATASET WITH DATA LINKED FROM SEVERAL ADMINISTRATIVE SOURCES. WE WILL FIRST CHARACTERIZE THE PREVALENCE AND TIME COURSE OF EVICTION PROCEEDINGS RELATIVE TO NON-FATAL OR FATAL OVERDOSE EVENTS BY CONDUCTING SEQUENCE AND CLUSTER ANALYSES TO OPERATIONALIZE VARIATION IN THE ORDER, DURATION, AND TIMING OF EVICTION PROCEEDINGS BEFORE AND AFTER A GIVEN OVERDOSE EVENT (AIM 1). WE WILL THEN ESTIMATE THE ADDRESS-LEVEL CAUSAL EFFECT OF RESIDENTIAL EVICTION PROCEEDINGS ON RISK OF NON-FATAL AND FATAL OVERDOSE, BOTH OVERALL AND BY RACE AND ETHNICITY OF OVERDOSE DECEDENTS, USING A SEQUENTIAL TARGET TRIAL APPROACH (AIM 2). THE PROPOSED RESEARCH WILL BE AMONG THE FIRST OF ITS KIND TO LINK EVICTION RECORDS WITH ADDRESS-LEVEL HEALTH DATA TO CHARACTERIZE HETEROGENEITY IN THE DURATION AND TIMING OF EVICTION PROCEEDINGS, TO EXAMINE A CAUSAL LINK BETWEEN EVICTION AND OVERDOSE, AND TO EXPLORE DIFFERENTIAL IMPACTS OF EVICTION ON OVERDOSE DEATH BY RACE AND ETHNICITY. BECAUSE EVICTION IS AN INTERVENABLE MECHANISM OF HOUSING VULNERABILITY THAT MAY BE ASSOCIATED WITH OVERDOSE RISK, FINDINGS FROM THIS WORK MAY ELUCIDATE NOVEL AVENUES FOR ADDRESSING THE INTERSECTING HOUSING AND OVERDOSE CRISES IN TANDEM. THE PROPOSED RESEARCH WILL BE COMPLETED BY THE PRINCIPAL INVESTIGATOR WITH SUPPORT AND MENTORSHIP FROM COLLABORATORS WITH SUBSTANTIAL EXPERTISE IN ADVANCED QUANTITATIVE METHODS FOR LIFE COURSE EPIDEMIOLOGY AND CAUSAL INFERENCE. THE TRAINING ACTIVITIES DETAILED IN THIS APPLICATION, FOCUSED ON ADVANCING SKILLS IN EPIDEMIOLOGIC STUDY DESIGN AND LONGITUDINAL DATA ANALYSIS AND DEVELOPING A DEEP CONTEXTUAL KNOWLEDGE OF THE SOCIAL AND LEGAL IMPLICATIONS OF EVICTION PROCEEDINGS, WILL PREPARE THE PRINCIPAL INVESTIGATOR FOR A CAREER AS AN INDEPENDENT SOCIAL EPIDEMIOLOGIST AND ACADEMIC RESEARCHER.

Posted 4/18/25